Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001104659-11-071275)

Filing Details

Accession Number:: 0001104659-11-071275
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2011-12-27 17:41:16
Reporting Period:: 2011-12-22

Filing Date:: 2011-12-27
Accepted Time:: 2011-12-27 17:41:16
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1130166	Cyclacel Pharmaceuticals Inc.	CYCC	Pharmaceutical Preparations (2834)	911766850

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1357396	George Spiro Rombotis	200 Connell Drive, Suite 1500 Berkeley Heights NJ 07922	President & C.e.o.	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, $0.001 Par Value Per Share	Acquisiton	2011-12-23	15,902	$0.50	746,516	No	4	P	Direct
Common Stock, $0.001 Par Value Per Share	Acquisiton	2011-12-22	75,000	$0.44	730,614	No	4	M	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	M	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Option	Disposition	2011-12-22	75,000	$0.00	75,000	$0.44

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2008-11-18	2018-11-18	No	4	M	Direct

Footnotes

Of the shares of common stock reported, 1,000 shares are held indirectly by Mr. Rombotis through his IRA account and 86,450 shares are represented by unvested restricted stock units.
These securities were granted to Mr. Rombotis under the Issuer's Amended and Restated 2006 Equity Incentive Plan.